Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
5/31/2025
China Approves First Homegrown Nine-Valent HPV Vaccine
5/31/2025
Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...
5/31/2025
China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM
5/31/2025
Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies
5/31/2025
Hansoh Receives NMPA Approval for Clinical Trials of Three Innovative ...
5/31/2025
China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...
5/31/2025
Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...
5/29/2025
First Patient Dosed in YK012 Trial -The World's First TCE Therapy for ...
5/29/2025
Rona Unveils Promising Preclinical Data for Annual RNAi Therapy
5/29/2025
China Grants Conditional Approval to Hengrui's Famitinib
5/29/2025
China Approves Zelgen's Gecacitinib
5/29/2025
China Grants Conditional Approval to Two HER2-Targeted Therapies for A...
5/29/2025
Kanion's Generic Sumatriptan/Naproxen Gains Approval in China
5/29/2025
China Approves Two New CDK4/6 Inhibitors for Advanced Breast Cancer
5/29/2025
Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...
5/29/2025
Kelun-Biotech Initiates Phase 1 Trial for SKB571, a Bispecific ADC Tar...
5/29/2025
Novartis Secures NMPA Approval for Beovu for DME in China
5/29/2025
Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED
5/27/2025
Hengrui's c-MET-Targeted ADC SHR-1826 Shows Promising Results in Phase...
5/27/2025
Eisai's Dayvigo Receives Approval in China for Insomnia
5/27/2025
DualityBio's HER3-Targeted ADC DB-1310 Shows Promising Early Results i...
5/27/2025
Salubris Pharma's S086 Receives Chinese Approval for Hypertension Trea...
5/27/2025
RemeGen's Telitacicept Gains Approval in China
5/27/2025
Juri Bio Secures Global Rights to Novel Prostate Cancer Immunotherapy ...
5/27/2025
FDA Approves China's First Homegrown Painkiller Qamzova
5/27/2025
Recce Pharma Secures Key China Patent
5/27/2025
Servier Acquires BioNova's Menin Inhibitor BN104
5/27/2025
Innovent's Mazdutide Demonstrates Significant Weight Loss in Phase 3 G...
5/27/2025
Zai Lab's ZL-1310 Shows Promising Results in Extensive-Stage SCLC
5/27/2025
Insilico Medicine Unveils AI-Designed ENPP1 Inhibitor ISM5939
Page:
1
/
14
Total number of articles:
405
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit